BioCatalyst

Acalabrutinib, Venetoclax, Chemoimmunotherapy, Obinutuzumab — catalyst calendar

1 verified catalyst event(s) referencing Acalabrutinib, Venetoclax, Chemoimmunotherapy, Obinutuzumab, each linked to its official source. Verified as of 2026-10-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-31
in 4mo
ESTIMATED
 READOUT
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With
Phase 3 · Chronic Lymphocytic Leukemia
 Acerta Pharma BV Acalabrutinib, Venetoclax, Chemoimmunoth ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.